Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy
Article in European Urology (February 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
The Potential of Congo Red Supplied Aggregates of Multitargeted Tyrosine Kinase Inhibitor (Sorafenib, BAY-43-9006) in Enhancing Therapeutic Impact on Bladder Cancer
Article in International Journal of Molecular Sciences (December 2023)
Morphological and mechanical changes induced by quercetin in human T24 bladder cancer cells
Article in Micron (September 2021)